The molecular heterogeneity of acute myeloid leukemia (AML) – new data and implications
Discussion of the two biologies of DLBCL - the GCB and ABC subtype and potential targeted therapies
The myeloma genome project and the aim to disseminate this worldwide
Recognizing clonal hematopoiesis – diagnostic challenges and clinical relevance
Is CLL curable today?